Jupiter Asset Management’s Medifast MED Stock Holding History

Jupiter Asset Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,062	Closed	-$856K	–	575
2021 Q4	$856K	Buy	+4,062	New	+$840K	0.01%	426
2021 Q1	–	Sell	-2,423	Closed	-$476K	–	619
2020 Q4	$476K	Hold	2,423	–	–	﹤0.01%	512
2020 Q3	$398K	Buy	+2,423	New	+$399K	﹤0.01%	521

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Jupiter Asset Management's MED Position: Q1 2022 in Review

Jupiter Asset Management sold out of Medifast (MED) in Q1 2022, closing a stake of 4,062 shares — an estimated $856K sold.

Jupiter Asset Management first reported a position in MED in Q3 2020 and held it in 3 quarters. The position peaked at $856K in Q4 2021. 288 funds tracked by Wall St. Rank hold MED as of Q1 2022.

Jupiter Asset Management reported no remaining Medifast position as of Q1 2022 after selling out during the quarter.
Jupiter Asset Management sold 4,062 Medifast shares in Q1 2022, an estimated $856K.
Jupiter Asset Management first reported a position in Medifast in Q3 2020 and held it in 3 quarters.
Jupiter Asset Management's Medifast position peaked at $856K in Q4 2021.
288 funds tracked by Wall St. Rank held Medifast as of Q1 2022.

Based on Jupiter Asset Management's 13F filing for Q1 2022, filed 11 May 2022.